Table 2.
Preoperative | |||
Age (years) | 56 | ||
PSA (ng/ml) | 1.63 | ||
Clinical Stage (%) | |||
T1a/b | 8% | ||
T1c | 26% | ||
T2 | 66% | ||
Biopsy Gleason Score | |||
6 | 89% | ||
7 | 7.8% | ||
8 | 2.6% | ||
Postoperative | |||
Tumor Volume | 2.76 ml | ||
RRP Gleason Score | |||
6 | 73% | ||
7 | 21% | ||
8 | 5% | ||
(+) Surgical Margins | 7.8% | ||
Extracapsular Tumor Extension | 9.1% | ||
Seminal Vesicle Invasion | 1.3% | ||
(+) Lymph Nodes | 0% | ||
Gleason | |||
Upgrading from | |||
Biopsy to RRP | 15.6% |